Pathology Lectures

Edema Caused by Microvascular Alveolar Injury

72 slides · PPTX & PDF available

Download PDF
Request PowerPoint

PowerPoint animations are preserved in the original file.

Marks are temporary. Tap a drawing tool again to stop.
Slide index (72)
  1. Loading slide titles…

Loading presentation…

Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.

Lecture topics

Slide index & full transcript (72 slides)

Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.

Slide 1 · Edema caused by microvascular (alveolar) injury

Noncardiogenic pulmonary edema, acute lung injury, and diffuse alveolar damage

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish permeability-related pulmonary edema from hydrostatic edema.

Explain endothelial and epithelial injury mechanisms in ALI/ARDS.

Correlate hyaline membranes, organizing injury, and clinical respiratory failure.

Interpret representative clinical scenarios using pathology mechanisms.

Slide 3 · Pulmonary edema has more than one mechanism

Hemodynamic edema

Primarily increased hydrostatic pressure

Common association: Left-sided heart failure

Alveolar fluid is mainly transudative

Alveolar wall–injury edema

Primary barrier injury and increased permeability

Endothelial and/or alveolar epithelial damage

Inflammatory, protein-rich exudate

Slide 4 · The intact alveolar–capillary barrier

ALVEOLAR AIR SPACE

INTERSTITIUM

PULMONARY CAPILLARY

Schematic · Thin alveolar epithelium, interstitium, and capillary endothelium

Slide 5 · Two cellular layers regulate alveolar dryness

Alveolar epithelium

Type I cells constitute thin gas-exchange lining

Type II pneumocytes maintain surfactant

Epithelial continuity supports edema clearance

Pulmonary capillary endothelium

Forms vascular interface of alveolar septum

Activation changes adhesion and permeability

Injury permits movement of inflammatory exudate

Slide 6 · Noncardiogenic edema begins with septal injury

Alveolar septal injury

Vascular permeability increases

Inflammatory exudate leaks

Interstitial → alveolar edema

Protein leakage follows a loss of barrier integrity rather than pressure overload alone.

Slide 7 · Primary endothelial injury: Vascular entry point

Endothelial activation or damage may initiate permeability edema.

Activated vessels become adhesive and proinflammatory.

Leakage starts in the interstitium and may reach the alveolar air spaces.

Epithelial injury often amplifies the pulmonary damage.

Slide 8 · Primary epithelial injury: Alveolar entry point

Pneumocyte damage

Alveolar macrophage sensing

TNF release

Secondary endothelial activation

Initial epithelial damage can trigger a secondary vascular inflammatory response.

Slide 9 · Severity changes the compartment containing fluid

Barrier insult

Interstitial fluid accumulation

More severe permeability loss

Intraalveolar exudate

Alveolar flooding represents more advanced injury than isolated interstitial edema.

Slide 10 · What the edema fluid signifies

Hemodynamic mechanism

Raised hydrostatic pressure

Transudate: Pale intraalveolar material

Often associated with vascular congestion

Inflammatory permeability mechanism

Endothelial or epithelial damage

Exudate: Protein-rich edema fluid

Fibrin and epithelial debris may form hyaline membranes

Slide 11 · Direct and indirect causes converge on the lung

Direct injury to the lung

Indirect / systemic injury

Infection

Bacterial or diffuse pneumonia

Aspiration

Gastric contents or near-drowning

Inhalation

Oxygen toxicity; Smoke; Irritant gases

Tissue injury

Contusion, trauma, radiation

Systemic

Sepsis; Burns; Pancreatitis; Trauma

Transfusion

Transfusion-associated lung injury

Drugs / chemicals

Listed medications and toxins

Other contexts

DIC, uremia, cardiopulmonary bypass

Slide 12 · Pulmonary infection is an important direct insult

Diffuse pulmonary infection is one of the principal associations with ARDS.

Textbook examples include viral, Mycoplasma, pneumocystis, and miliary tuberculosis.

Bacterial pneumonia can directly injure the alveolar wall.

Local epithelial injury can provoke macrophage-dependent inflammation.

Slide 13 · Aspiration exposes alveoli to damaging material

Gastric aspiration

Direct alveolar injury

Inflammation and barrier leak

ALI/ARDS

The initiating insult occurs directly at the alveolar surface.

Slide 14 · Inhaled agents can injure the alveolar septum

High oxygen concentrations may produce oxygen toxicity.

Smoke and irritant gases are recognized inhalational triggers.

These are lung-directed injuries rather than isolated elevation of venous pressure.

Clinical context identifies the injurious exposure.

Slide 15 · Physical and environmental lung injury

Pulmonary contusion follows direct thoracic injury.

Near-drowning introduces liquid-associated lung injury.

Radiation and severe burns are among listed injury contexts.

Major mechanical trauma, including head injury, is associated with ARDS.

Slide 16 · Systemic inflammation can initiate lung injury

Severe systemic insult

Circulating mediators

Pulmonary endothelial activation

Permeability edema

A distant source of inflammation can damage the alveolar–capillary interface.

Slide 17 · Sepsis is a major associated trigger

Circulating inflammatory signals can activate pulmonary capillary endothelium directly.

Endothelial changes recruit neutrophils and favor barrier dysfunction.

Sepsis can coexist with other injuries, intensifying pulmonary damage.

Sepsis among the prominent ARDS-associated conditions.

Slide 18 · Transfusion and hematologic associations

Transfusion-associated lung injury appears in the list of ARDS associations.

Disseminated intravascular coagulation is another listed hematologic context.

Systemic and hematologic insults can converge on pulmonary endothelial injury.

Association alone does not specify a unique histologic pattern.

Slide 19 · Drugs and chemicals are heterogeneous triggers

Examples

Heroin or methadone overdose

Aspirin or barbiturate overdose

Paraquat and other chemicals

Pathology implication

A chemical or medication exposure may precede ALI.

The common consequence is alveolar wall injury.

Drug history helps identify the initiating condition.

Slide 20 · Multiple concurrent insults may coexist

Concurrent systemic insults

Sepsis and severe tissue injury

Shock and extensive trauma

More than one trigger may be present

Coexisting pulmonary stresses

Oxygen therapy may coexist

Diffuse pulmonary infection may coexist

Combined insults can worsen lung damage

Slide 21 · ALI is a clinicopathologic lung-injury syndrome

An abrupt onset of hypoxemia.

Bilateral pulmonary edema occurs without cardiac failure as the explanation.

Increased pulmonary vascular permeability accompanies epithelial cell death.

The resulting histologic injury pattern is diffuse alveolar damage.

Slide 22 · ARDS represents severe acute lung injury

Acute barrier injury

Permeability-related edema

Progressive oxygenation failure

ARDS

Severe permeability edema is coupled to worsening gas-exchange failure.

Slide 23 · ARDS and DAD are not interchangeable labels

ARDS

Clinical syndrome

Severe acute respiratory insufficiency

Often occurs with identifiable systemic or pulmonary trigger

Diffuse alveolar damage (DAD)

Histologic pattern of injury

Edema, epithelial damage, hyaline membranes

May evolve into organizing/fibroproliferative injury

Slide 24 · Acute interstitial pneumonia: No identified trigger

A minority of acute presentations occur without known initiating conditions.

The source calls this rapidly progressive presentation acute interstitial pneumonia.

Distinction from triggered ALI/ARDS is clinical, chiefly whether a precipitant is found.

Similar forms of acute lung injury may occur in either setting.

Slide 25 · The early injury has multiple cellular targets

Alveolar compartment

Type I and type II pneumocytes

Resident alveolar macrophages

Injury may begin at epithelial surfaces

Vascular and recruited cells

Pulmonary endothelial cells

Circulating and migrating neutrophils

Cell interactions amplify barrier dysfunction

Slide 26 · Macrophages translate epithelial injury into signals

Epithelial injury

Alveolar macrophage sensing

TNF release

Endothelial activation

Resident macrophages connect tissue damage with endothelial inflammation.

Slide 27 · Systemic mediators provide a second initiating route

Sepsis or severe tissue injury

Circulating inflammatory mediators

Pulmonary endothelium

Activation and damage

Endothelial activation can occur even without a primary airway insult.

Slide 28 · Endothelial activation changes the vessel surface

Functional change

Increased adhesion molecules

Increased procoagulant proteins

Chemokine expression

Pathologic effect

Facilitates neutrophil attachment

Promotes a procoagulant endothelial phenotype

Supports leukocyte recruitment into lung

Slide 29 · Neutrophils cross the activated capillary wall

Adhere to endothelium

Pass into interstitium

Enter alveolar spaces

Release injurious mediators

Slide 30 · Activated neutrophils amplify damage

Proteases can damage cellular and extracellular components.

Reactive oxygen species contribute to inflammatory tissue injury.

Cytokines reinforce recruitment and activation of inflammatory cells.

This amplifies microvascular and alveolar epithelial damage.

Slide 31 · NETs: A possible additional source of damage

Neutrophil extracellular traps (NETs) may be released in ALI/ARDS.

Experimental evidence supporting a direct damaging contribution.

NETs supplement, rather than replace, protease and oxidant-mediated injury.

The degree of contribution is not quantified in the supplied source.

Slide 32 · Inflammation creates a self-amplifying loop

Endothelial activation

Neutrophil recruitment

Proteases · ROS · cytokines

Worsening tissue damage

Amplified inflammation feeds back to injure the barrier

Further endothelial damage perpetuates permeability and leukocyte activation.

Slide 33 · The damaged barrier permits alveolar exudation

ALVEOLAR AIR SPACE

Protein-rich edema

Epithelial loss

INTERSTITIUM

PULMONARY CAPILLARY

Increased permeability

Schematic · Endothelial–epithelial injury allows exudation into air spaces

Slide 34 · Type II cell injury compromises surfactant

Type II pneumocyte damage

Surfactant abnormalities

Reduced alveolar function

Worse gas exchange

Surfactant disruption adds mechanical dysfunction to barrier leakage.

Slide 35 · Hyaline membranes form from edema and cell debris

Exudative fluid component

Protein-rich alveolar edema fluid

Fibrin-rich deposits along injured walls

Contributes the proteinaceous matrix

Necrotic cellular component

Damaged pneumocyte remnants

Cellular debris admixed with fibrin

Combined material forms hyaline membranes

Slide 36 · Hyaline membranes identify exudative DAD

The membranes line injured alveolar walls.

They are composed of fibrin-rich fluid and epithelial necrotic debris.

Them as waxy on histologic sections.

They are characteristic of DAD, but are not a separate ARDS diagnostic test.

Slide 37 · Edema removal is impaired by epithelial injury

Pneumocyte necrosis

Impaired fluid-resorption capacity

Persistence of alveolar fluid

Sustained gas-exchange impairment

The same injury that causes flooding also slows fluid resolution.

Slide 38 · ALI/ARDS is patchy at the functional level

Poorly aerated regions

Lower regional compliance

Alveolar edema and epithelial damage

Persisting pulmonary perfusion

Relatively preserved regions

Near-normal compliance may remain

Ventilation can be relatively maintained

Substantial within-lung heterogeneity

Slide 39 · Perfused but underventilated units worsen hypoxemia

Relatively preserved unit

Poorly aerated injured unit

Ventilation preserved

Perfusion continues

Ventilation ↓

Perfusion continues

Perfusion of poorly ventilated alveoli worsens arterial hypoxemia.

Slide 40 · Why supplemental oxygen may be insufficient

Edema / low aeration

Ventilation–perfusion mismatch

Marked hypoxemia

Oxygen therapy may not normalize it

Poorly aerated but perfused alveoli contribute to severe oxygenation defects.

Slide 41 · Reduced lung compliance increases ventilatory demand

Loss of functional surfactant contributes to stiff lungs.

Some involved units become poorly aerated and low-compliance.

Severe respiratory failure may require intubation.

High ventilatory pressures may be necessary to maintain gas exchange.

Slide 42 · The exudative phase changes gross lung appearance

Lungs become heavy and firm because of accumulated fluid and tissue injury.

They are characteristically red and boggy.

Capillary congestion and interstitial edema occur together.

In more advanced involvement, alveolar spaces contain exudate.

Slide 43 · Exudative DAD: Core microscopic changes

Congestion accompanies interstitial and intraalveolar edema.

Inflammation and fibrin deposition are present.

Necrosis of alveolar epithelial cells contributes to tissue damage.

Hyaline membranes line injured alveoli.

Slide 44 · Schematic recognition of hyaline membranes

Alveolar air space

Hyaline membrane: Fibrin-rich exudate + epithelial remnants

Schematic only — not H&E photomicrograph

Slide 45 · Membrane composition explains its appearance

Derived from edema fluid

Protein-rich exudate

Fibrin accumulation

Inspissated material along alveolar surfaces

Derived from damaged epithelium

Necrotic epithelial fragments

Cellular debris

Admixture with fibrinous exudate

Slide 46 · Radiology mirrors uneven airspace injury

Acute disease can show patchy ground-glass opacities.

Consolidation may coexist with ground-glass regions.

Diffuse bilateral infiltrates develop with clinical respiratory failure.

Imaging findings complement but do not replace pathologic context.

Slide 47 · Organizing injury follows the exudative phase

Exudative alveolar damage

Type II cell proliferation

Granulation tissue formation

Organizing lung injury

Inflammatory injury is followed by regeneration and fibroblastic organization.

Slide 48 · Type II pneumocytes participate in repair

Proliferation of surviving type II pneumocytes is characteristic of organizing DAD.

Residual type II cells can replace lost type I pneumocytes.

Re-epithelialization helps restore the alveolar lining.

Repair can progress over an extended period.

Slide 49 · Granulation tissue appears in organizing DAD

The organizing phase involves granulation tissue in alveolar walls.

Granulation tissue can also develop within alveolar spaces.

Fibroblastic activity follows prior injury and inflammation.

The extent of organization influences subsequent structural recovery.

Slide 50 · DAD evolves through recognizable responses

Exudative injury

Capillary leak; Edema; Epithelial death; Hyaline membranes

Organizing response

Type II pneumocyte proliferation and granulation tissue

Divergent outcome

Alveolar repair and recovery or collagen deposition with fibrosis

Slide 51 · Fibrogenic mediators follow inflammatory clearance

Macrophage activity

TGF-β and PDGF

Fibroblast growth

Collagen deposition

Tissue repair can become a fibrogenic response after severe injury.

Slide 52 · Collagen deposition can remodel alveolar walls

Fibroblasts deposit collagen in previously injured alveolar septa.

The wall becomes fibrotic when repair remains fibroproliferative.

Fibrosis reduces normal architectural flexibility.

Persistent interstitial fibrosis can contribute to chronic pulmonary disease.

Slide 53 · Inflammatory clearance is part of resolution

Trigger diminishes

Macrophage clearance

Debris removed

Repair pathways continue

Resolution requires the original inflammatory trigger to subside.

Slide 54 · Epithelial repair reconstitutes alveolar lining

Surviving type II cells

Type II proliferation

Replacement of type I cells

Lining restored

Surviving type II cells supply regenerative potential for the epithelial surface.

Slide 55 · Endothelial integrity can also recover

Proliferation of uninjured capillary endothelial cells supports restoration.

Repair must occur on the vascular side as well as in the alveolar lining.

Edema resolution becomes more feasible as epithelial function recovers.

The balance between restoration and fibrosis helps determine outcome.

Slide 56 · The recovery pathway is not uniform

Recovery / resolution

Inflammatory stimuli subside

Debris clearance and cell regeneration

Most survivors recover pulmonary function

Persistent structural disease

Fibroproliferation and collagen deposition

Residual interstitial fibrosis

Potential chronic pulmonary limitation

Slide 57 · Clinical onset is often abrupt and severe

Profound dyspnea and rapid breathing are prominent early findings.

Progressive hypoxemia may produce cyanosis.

Respiratory failure evolves with increasing bilateral lung opacities.

The syndrome is commonly observed in critically ill patients.

Slide 58 · Respiratory failure reflects several coupled lesions

Alveolar edema

Surfactant dysfunction

Regional low compliance

Gas-exchange failure

Barrier failure, surfactant loss, and regional low compliance act together.

Slide 59 · Morphology, physiology, and imaging align

Structural lesion

Interstitial / alveolar edema

Hyaline membranes and cell necrosis

Uneven airspace involvement

Functional consequence

Impaired diffusion and ventilation

Reduced functional surfactant

V/Q mismatch and refractory hypoxemia

Slide 60 · Outcomes depend on injury and systemic illness

Fatal outcomes may be associated with sepsis and multiorgan failure.

Severe lung injury itself also contributes to mortality.

Most survivors recover pulmonary function.

A minority develop interstitial fibrosis with chronic pulmonary disease.

Slide 61 · Historical ICU data: Interpret within its period

A 2016 study conducted in ICUs across 50 countries.

ARDS accounted for 10.4% in that reported ICU study.

Reported mortality was 35%, 40%, and 46% for mild, moderate, and severe ARDS.

These are historical study estimates—not present-day universal probabilities.

Slide 62 · Host factors may modify risk

Epidemiologic studies cited link smoking with worse ARDS prognosis.

Alcohol use disorder is also associated with greater susceptibility and poorer outcomes.

Genetic variants associated with risk include loci connected to inflammation or coagulation.

The supplied text does not define a clinical genetic risk test.

Slide 63 · Injury edema and hemodynamic edema differ

Feature

Hemodynamic pulmonary edema

Microvascular injury edema

Principal mechanism

Hydrostatic pressure increase

Endothelial / epithelial injury

Common context

Left-sided cardiac failure

Sepsis, aspiration, severe lung injury

Fluid character

Transudate

Protein-rich inflammatory exudate

Characteristic histology

Congestion; Heart-failure cells possible

DAD; Hyaline membranes may develop

Slide 64 · Clinical case: Septic patient with bilateral edema

A critically ill patient with sepsis develops abrupt breathlessness, hypoxemia, and bilateral pulmonary opacities. No cardiac failure is identified.

Interpretation prompts

What makes permeability edema likely?

Which pulmonary cell surface is activated early?

Name the characteristic histologic injury pattern.

Slide 65 · Case interpretation: Sepsis-associated lung injury

Systemic mediators may directly activate pulmonary microvascular endothelium.

Neutrophil recruitment and epithelial injury produce permeability exudation.

The associated histologic pattern is diffuse alveolar damage.

Hyaline membranes may occur in the exudative phase.

Slide 66 · Clinical case: Hydrostatic or permeability edema?

One patient with left-sided cardiac failure develops congested, fluid-filled lungs. Another has acute respiratory failure after gastric aspiration.

Interpretation prompts

Which is more consistent with increased hydrostatic pressure?

Which is more consistent with direct alveolar wall injury?

How would the expected edema character differ?

Slide 67 · Case interpretation: Identify the mechanism

Left-sided heart failure commonly raises hydrostatic pressure and produces transudative edema.

Gastric aspiration directly injures lung tissue and may cause inflammatory edema.

Microvascular injury can cause DAD with hyaline membranes.

Clinical context and tissue changes distinguish the mechanisms.

Slide 68 · Clinical case: Organizing lung injury

Following severe acute lung injury, surviving tissue shows type II pneumocyte proliferation, granulation tissue, and emerging collagen deposition.

Interpretation prompts

Which phase of diffuse alveolar damage is represented?

What cells rebuild the alveolar epithelial surface?

What could determine persistent physiologic impairment?

Slide 69 · Case interpretation: Organizing DAD

The proliferative or organizing phase follows exudative alveolar injury.

Residual type II pneumocytes regenerate lining cells, including type I cells.

Fibrogenic mediators stimulate fibroblast growth and collagen deposition.

Extensive fibrosis can contribute to chronic lung dysfunction.

Slide 70 · Integrated pathogenesis of injury-related edema

Direct or systemic insult

Endothelial / epithelial injury

Inflammation and protein-rich edema

DAD ± fibrosis

Histologic DAD and the clinical ARDS phenotype are related but distinct.

Slide 71 · Five mechanistic points to retain

The defining mechanism is alveolar wall injury with increased vascular permeability.

Local epithelial damage or systemic inflammation can activate endothelium.

Neutrophil mediators sustain an injury–inflammation feedback loop.

Protein-rich edema plus epithelial debris produces hyaline membranes.

Recovery requires epithelial/endothelial repair; Some cases evolve toward fibrosis.

Slide 72 · Primary references and source boundaries

Robbins, Cotran & Kumar

Pathologic Basis of Disease, 11th edition (2026), Chapter 15: The Lung

Pulmonary edema, acute lung injury, ARDS, and diffuse alveolar damage; printed pages 614–617.

Relevant source tables: 15.1 and 15.2; referenced textbook figures: 15.3 and 15.4.

Privacy preferences

Essential storage remembers your theme and privacy choice. Secure forms and teaching requests remain available whichever option you choose.

Teaching activity uses separate aggregate counters and short-lived sessions. SlideShare links open the original presentations on SlideShare. Form security checks are provided by third parties.

No message text, email addresses, visitor identifiers, or destination URLs are included in optional measurement. Read privacy details